Cascadian Therapeutics, Inc. SEC Filings

Filed On	Filing
11 Apr 2019	CT ORDER
22 May 2018	CT ORDER
09 Apr 2018	NONE
22 Mar 2018	15-12B
21 Mar 2018	EFFECT
21 Mar 2018	EFFECT
21 Mar 2018	EFFECT
21 Mar 2018	EFFECT
19 Mar 2018	GROWTH EQUITY OPPORTUNITIES FUND IV, LLC --- CASCADIAN THERAPEUTICS, INC. - SCHE
13 Mar 2018	Form 4: Walker Luke Nathaniel, SVP, Clinical Development Disposed of 10,315 shares (Tender Offer) · Disposed of 127,936 Stock Option (Right to buy) (Disposition to Issuer) · Disposed of 149,800 Restricted Stock Units (Disposition to Issuer)
13 Mar 2018	Form 4: James Steven P, Director Disposed of 13,677 shares (Tender Offer) · Disposed of 13,927 Restricted Stock Units (Disposition to Issuer)
13 Mar 2018	Form 4: Love Ted W, Director Disposed of 37,394 shares (Tender Offer) · Disposed of 13,927 Restricted Stock Units (Disposition to Issuer)
13 Mar 2018	Form 4: Fyfe Gwen A., Director Disposed of 10,125 shares (Tender Offer) · Disposed of 13,927 Restricted Stock Units (Disposition to Issuer)
13 Mar 2018	Form 4: Viswanathan Ravi, 10% owner Disposed of 10,882,574 shares (Tender Offer)
13 Mar 2018	Form 4: Sonsini Peter W., 10% owner Disposed of 10,882,574 shares (Tender Offer)
13 Mar 2018	Form 4: Sandell Scott D, 10% owner Disposed of 10,882,574 shares (Tender Offer)
13 Mar 2018	Form 4: Sakoda Jon, 10% owner Disposed of 10,882,574 shares (Tender Offer)
13 Mar 2018	Form 4: Mott David M, 10% owner Disposed of 10,882,574 shares (Tender Offer)
13 Mar 2018	Form 4: Makower Joshua, 10% owner Disposed of 10,882,574 shares (Tender Offer)
13 Mar 2018	Form 4: Peterson Scott Robert, Chief Scientific Officer Disposed of 3,639 shares (Tender Offer) · Disposed of 287,036 Stock Option (Right to buy) (Disposition to Issuer) · Disposed of 180,800 Restricted Stock Units (Disposition to Issuer)

Comments